Free Trading + Demat Account

Laurus Labs Ltd IPO (Laurus Labs IPO) Detail

Dec 6, 2016 - Dec 8, 2016

Incorporated in 2005, Laurus Labs Ltd is Hyderabad based pharmaceutical company. Laurus Labs is in the business of manufacturing generic active pharmaceutical ingredients (APIs) for therapeutic areas of antiretrovirals (ARVs) and Hepatitis C. Company also manufacture APIs in oncology and other therapeutic areas.

Laurus Labs operates in four business lines:
1. Generics active pharmaceutical ingredients (APIs) - The development, manufacture and sale of APIs and advanced intermediates.
2. Generics finished dosage forms (FDFs) - The development and manufacture of oral solid formulations.
3. Synthesis - Contract development and manufacturing services for global pharmaceutical companies.
4. Ingredients - The manufacture and sale of specialty ingredients for use in the nutraceutical and cosmeceutical sectors.

Key Highlights:
1. Laurus Labs launched 59 products since our inception in 2005.
2. Nine out of the 10 largest generic pharmaceutical companies in the world are its customers.
3. Laurus Labs employed 587 scientists at our R&D center in Hyderabad and 12 scientists at R&D centre in Greater Boston USA.
4. The Company owned 32 patents and had 150 pending patent applications, in several countries.
5. Company has three manufacturing facilities in Visakhapatnam, Andhra Pradesh.
6. Company sells its products in 32 countries in Sub-Saharan Africa, South-East Asia and Latin America.

Key Strengths:
1. Leadership in APIs in Select, High Growth Therapeutic Areas
2. Strong R&D Capabilities and Process Chemistry Skills
3. Industry Leading, Modern and Regulatory Compliant Manufacturing Capacities
4. Long-standing Relationships with Multi-National Pharmaceutical Companies
5. Experienced Promoters and Qualified Operational Personnel
6. Established Track Record of Delivering Growth

Company Promoters:

The Promoters of the company are:

1. Dr Satyanarayana Chava
2. Naga Rani Chava
3. Dr Raju Srihari Kalidindi
4. Ravi Kumar V V and
5. Dr Lakshmana Rao C V

Company Financials:

Summary of financial Information
Particulars For the year/period ended (in Rs. Million)
31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12
Total Assets 23,083.48 18,925.49 12,730.58 7,009.89 5,128.78
Total Revenue 17,884.15 13,603.80 11,685.34 7,235.67 4,523.07
Profit After Tax (PAT) 1,435.68 735.17 972.17 882.19 215.77

Objects of the Issue:

The object of the issue are to:
1. Pre-payment of term loans; and
2. General corporate purposes.

Issue Detail:

  »»  Issue Open: Dec 6, 2016 - Dec 8, 2016
  »»  Issue Type: Book Built Issue IPO
  »»  Issue Size:
    ›  Fresh Issue of [.] Equity Shares of Rs 10 aggregating up to Rs 300.00 Cr
    ›  Offer for Sale of 24,107,440 Equity Shares of Rs 10 aggregating up to Rs [.] Cr
  »»  Face Value: Rs 10 Per Equity Share
  »»  Issue Price: Rs. 426 - Rs. 428 Per Equity Share
  »»  Market Lot: 35 Shares
  »»  Minimum Order Quantity: 35 Shares
  »»  Listing At: BSE, NSE

Laurus Labs IPO Reviews:

  1. Laurus Labs Ltd IPO review by Dilip Davda

Issue Subscription Detail / Current Bidding Status

Number of Times Issue is Subscribed (BSE + NSE)
As on Date & TimeQIBNIIRIIEmployeeTotal
Shares Offered / Reserved6,174,5444,623,87910,789,051323,83421,911,308
Day 1 - Dec 6, 2016 17:00 IST0.71000.16000.10000.04000.2800
Day 2 - Dec 7, 2016 17:00 IST1.02000.54000.39000.98000.6100
Day 3 - Dec 8, 2016 18:18 IST10.53953.57441.58031.70844.5282

Laurus Labs IPO Prospectus

Laurus Labs IPO Rating

774
4.2
Rating:Rated 4.2 stars

Vote Here ...

Laurus Labs IPO Listing Date

  •   ›  Listing Date: Monday, December 19, 2016
  •   ›  BSE Script Code: 540222
  •   ›  NSE Symbol: LAURUSLABS
  •   ›  Listing In: ‘B’ Group of Securities
  •   ›  ISIN: INE947Q01010
  •   ›  Issue Price: Rs. 428.00 Per Equity Share
  •   ›  Face Value: Rs. 10.00 Per Equity Share

Listing Day Trading Information

BSE
Issue Price:Rs. 428.00
Open:Rs. 490.00
Low:Rs. 475.00
High:Rs. 498.00
Last Trade:Rs. 480.50
Volume:3,952,346
NSE
Rs. 428.00
Rs. 489.90
Rs. 475.00
Rs. 498.00
Rs. 480.40
17,548,335

Laurus Labs IPO News Alerts

  1. Monday, December 19, 2016 12:00:00 AM
    Laurus Labs Ltd IPO - Listing
  2. Thursday, December 15, 2016 12:00:00 AM
    Laurus Labs Ltd IPO - Allotment
  3. Thursday, December 8, 2016 12:00:00 AM
    Laurus Labs Ltd IPO - Close
  4. Tuesday, December 6, 2016 12:00:00 AM
    Lauras Labs Ltd IPO - Open

Company Contact Information

Laurus Labs Ltd
Plot No.21,
Jawaharlal Nehru Pharma City,
Parawada, Visakhapatnam 531 021
Phone: + 91 40 3980 4333
Fax: +91 40 3980 4320
Email: secretarial@lauruslabs.com
Website: http://www.lauruslabs.com

Laurus Labs IPO Registrar

Karvy Computershare Private Limited   »  Report
   Karvy House, 46, Avenue 4, Street No. 1,
   Banjara Hills, Hyderabad - 500 034
   Andhra Pradesh, India

Phone: +91-40-23312454
Fax: +91-40-23311968
Email: einward.ris@karvy.com
Website: http://karisma.karvy.com

Stock Brokers in India (Detailed Comparison)

We provide detail comparison of stock / commodities brokeRs We helped over 75,000 traders/investors to save 60% or more brokerage in last 3 yeaRs Here is the list of popular brokers to help investors like you to find the best broker.

We can help you choosing the right broker. Contact us today...

@

Laurus Labs IPO Review / Comments

avatar
1304. Sps  Feb 28, 2017 5:28:00 PM IST | I Like It. | Report Abuse Reply
laurus labs hold kare ya sell karde plz expert suggest
avatar
1303. Hardik Chudgar  Feb 21, 2017 3:10:10 PM IST | I Like It. | Report Abuse Reply
Laurus jumps around 518. Should wait or exit??
avatar
1302. nona  Feb 21, 2017 12:52:11 PM IST | I Like It. | Report Abuse Reply
gamble ji

lauras lab kab jagega

thank u
avatar
1301. A patel..Gujarat..  Feb 16, 2017 1:24:59 PM IST | I Like It. 1 | Report Abuse Reply
Laurus exit tatget 428..few days..exit.. issue prise coming up..
avatar
1300. rvr  Feb 16, 2017 9:14:37 AM IST | I Like It. 1 | Report Abuse Reply
laurus will sail to 580 shortly
avatar
1299. rvr  Feb 16, 2017 9:14:05 AM IST | I Like It. 1 | Report Abuse Reply
LAURUS will reach 580 in 2 days...
avatar
1298. A patel..Gujarat..  Feb 15, 2017 2:58:04 PM IST | I Like It. 1 | Report Abuse Reply
Exit laurus lab. And Buy Sun farma...Best Retun in Short time..
avatar
1297. NPT  Feb 10, 2017 8:01:26 PM IST | I Like It. 1 | Report Abuse Reply
I have positive outlook on Laurus Labs for the 4th quarter result because company will be benefitted from operation of its new unit which started production in Nov 2016. The company is expected to get some parents during the quarter. Company bottom line will improve because of payment of debts to the tune of R''s.226 crores from the ipo proceeds. There is a chance that in the short run it may test R''s.480 level again.
avatar
1297.1. AKH  Feb 11, 2017 1:35:15 PM IST | I Like It. 1 | Report Abuse
The company is expected to get "Some Parents" what is this ?
avatar
1297.2. NPT  Feb 11, 2017 4:24:55 PM IST | I Like It. 1 | Report Abuse
It is a typing mistake. It is patent, not parents.
avatar
1296. CLD  Feb 10, 2017 12:12:27 PM IST | I Like It. 2 | Report Abuse Reply
No body is answering the question of people about selling or holding of the shares they are holding. I have already got my whats up group members to book part profits yesterday at 560. I don''t know why people are not helping others. No body is expert in market still experienced people can give suggestions. My previous posts can be seen by clicking on my name.
avatar
1296.1. AKH  Feb 10, 2017 4:43:31 PM IST | I Like It. 1 | Report Abuse
Actually questioner ask question to Eagleye, gamble and usually they dont reply.
avatar
1296.2. mark bab  Feb 10, 2017 6:37:44 PM IST | I Like It. 1 | Report Abuse
and whats ur view on cpse etf...should profit be booked. i hv since its ipo of 2014.
avatar
1296.3. Shivajee  Feb 16, 2017 7:47:26 AM IST | I Like It. 1 | Report Abuse
I like this post by CLD. True. But gamble is very helpful, he responds to questions by the inexperienced.

Nobody says how they became experts also. It is better to teach people how to catch fish rather than catching them, cooking and then feeding to people.

avatar
1296.4. nona  Feb 16, 2017 12:00:42 PM IST | I Like It. 2 | Report Abuse
shivajee sir

I do agree with YOU
avatar
1295. gamble  Feb 10, 2017 9:20:26 AM IST | I Like It. 1 | Report Abuse Reply
Avg. set of numbers.
...stock already priced in this type of no.s
avatar
1294. VALUE INVESTOR  Feb 10, 2017 4:48:38 AM IST | I Like It. 1 | Report Abuse Reply
LinkExternal Link

Laurus Laboratories posted a 17.5 percent increase in net profit to Rs 47.2 crore in the third quarter ended December on account of larger uptake of its API business.
avatar
1294.1. Cbm  Feb 10, 2017 11:10:43 AM IST | I Like It. 1 | Report Abuse
Experts,
kindly let me you views about Laurus Lab
whether it sell or hold
avatar
1294.2. AKH  Feb 10, 2017 4:51:09 PM IST | I Like It. 1 | Report Abuse
@CBM
Actually experts dont reply. My opinion is to hold till results of next quarter, if you can
avatar
1293. Umang & his ultrasonic uproar  Feb 9, 2017 7:58:21 PM IST | I Like It. 1 | Report Abuse Reply
Laurus labs result is out... Pls see on bse site(corporate announcements). Pls analyze Mr Septa, Mr gamble and help us understand weather it is good or not
avatar
1293.1. NPT  Feb 9, 2017 8:52:16 PM IST | I Like It. 1 | Report Abuse
Apprx 10% growth in total revenue in comparison to last year''s nine months result.
PAT for the nine months has increased by apprx 40% over the last year''s first nine months pat.
However, it appears to me that both total revenue and pat for the current quarter has declined in comparison to September quarter which is a concern to me.
Let us see how the market will respond to the result.
My I am not very much hopeful for upside tomorrow though I have one lot. Not going to sale also.
I am just a beginner, not much exposure in the share market. Just an ordinary investor with little analytical knowledge.
avatar
1293.2. NPT  Feb 9, 2017 9:13:55 PM IST | I Like It. 2 | Report Abuse
One more positive note in the result is that its total revenue and pat for December 16 quarter has increased in comparison to the December 2015 quarter''s results.
avatar
1293.3. VALUE INVESTOR  Feb 9, 2017 9:30:36 PM IST | I Like It. 1 | Report Abuse
Let''s see how market react tomorrow.
avatar
1292. Chem cho  Feb 8, 2017 5:57:48 PM IST | I Like It. 2 | Report Abuse Reply
Laurus was trading between 475 to 480 from jan 17 from 3 feb movement was seen in this script now it has risen to high of RS 585 and todays low of Rs 546

script is worth holding at ipo price those who got allotment for better target than Rs 600



avatar
1291. deepika  Feb 7, 2017 3:52:25 PM IST | I Like It. 1 | Report Abuse Reply
LAURUS LAB

TARGET 600-650 FEB MONTH 100%
avatar
1291.1. AJ''s Actions  Feb 7, 2017 6:29:04 PM IST | I Like It. 1 | Report Abuse
Is this true news?
avatar
1291.2. rvr  Feb 8, 2017 9:01:06 PM IST | I Like It. 1 | Report Abuse
in market nothing is true....only predictions..
avatar
1290. deepika  Feb 7, 2017 3:52:23 PM IST | I Like It. | Report Abuse Reply
LAURUS LAB

TARGET 600-650 FEB MONTH 100%
avatar
1289. deepika  Feb 7, 2017 3:18:58 PM IST | I Like It. | Report Abuse Reply
KINDLY BUY LAURUS

TARGET 590 ONLY 2 DAYS
avatar
1288. A patel..Gujarat..  Feb 7, 2017 1:51:02 PM IST | I Like It. | Report Abuse Reply
2 lot sold. 583.70...
avatar
1287. CA M&co.Jodhpur  Feb 7, 2017 11:30:55 AM IST | I Like It. 1 | Report Abuse Reply
Sell Laurus lab and buy Alkem Lab for best return in this year.
Alkem lab near 52week high very strong fundamental strong pharmaceutical company.
avatar
1287.1. CA M&co.Jodhpur  Feb 13, 2017 12:54:19 PM IST | I Like It. 1 | Report Abuse
My expectations is correct.see Alkem Lab at new 52 week high.and laurus down.
Buy Alkem Lab instead of Lauruse lab.
avatar
1286. s.selvam  Feb 6, 2017 9:23:51 PM IST | I Like It. | Report Abuse Reply
Though I have not been allotted in BSE IPO I have been allotted LAURUS LAB AND IT TESTED MY PATIENCE FOR QUITE A LONG TIME.IT OSCILATES AROUND RS.472/- TO RS.480/- FOR QUITE A LONG TIME.EAGLE EYE MADAM I THANK U AFTER SEEING YOUR MESSAGE TO HOLD. I HAVE NOT SOLD THOSE SHARES.NOW I AM REACHING THE BENEFITS.LATER ONLY I KNOW THAT THEY ARE ONE OF API OF MEDICINES FOR ONCOLOGY AND HEPATITIS.I THANK ONCE AGAIN EAGLE EYE MADAM I AM HOLDING 70 SHARES OF LL WHICH I WILL GIFT IT TO MY GRAND DAUGHTER AND GRAND SON..
avatar
1285. CA Bhaumik Shah  Feb 6, 2017 6:39:43 PM IST | I Like It. | Report Abuse Reply
Dear Eagleye

What will be the next target ?
Whether it may go to 650 to 700 ?
special_offers
By Popular Stock Brokers
ProStocks, The Flat Rate Discount Stock Broker
ProStocks
Flat Fee Broker

Rs 899 Unlimited Equity
Rs 499 Unlimited Curr
or Rs 15 per Trade

Lowest Transaction Charge
Lowest Call & Trade Fee
Lowest Stamp Duty

FREE Trading + Demat Acct

Flat Rs 20 Per Trade
Free Equity Delivery Trades

Rs 100 off on account opening* + 100% brokerage refund if in 60 days you have made net profits

Enquire Now
(* on online account opening)

Intraday @ 0.02%
Delivery @ 0.15%

Rs 0 account opening fee
(Rs 400 waived)

Request Demo

RKSV Discount Broker  RKSV

Ditch & Switch

Switch to RKSV and earn brokerage credit of Rs 2000

Get RKSV Trading Account

Beginner, seasoned investor, active trader or HNI. Get customised solutions.

Rs 0 account opening fee on Online Trading + Demat Acct
(Rs 1150 waived)

Request Call Back



More About Brokers

Special Offers Broker Reports

Message Board

Stock Message Board


Search Chittorgarh.com:

Translate Chittorgarh.com: